DE69728447D1 - Veränderte, kleine rna-viren - Google Patents

Veränderte, kleine rna-viren

Info

Publication number
DE69728447D1
DE69728447D1 DE69728447T DE69728447T DE69728447D1 DE 69728447 D1 DE69728447 D1 DE 69728447D1 DE 69728447 T DE69728447 T DE 69728447T DE 69728447 T DE69728447 T DE 69728447T DE 69728447 D1 DE69728447 D1 DE 69728447D1
Authority
DE
Germany
Prior art keywords
rna viruses
small rna
changed small
vlps
changed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69728447T
Other languages
English (en)
Other versions
DE69728447T2 (de
Inventor
Heinrich Gordon
Nelson Hanzlik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Application granted granted Critical
Publication of DE69728447D1 publication Critical patent/DE69728447D1/de
Publication of DE69728447T2 publication Critical patent/DE69728447T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00023—Virus like particles [VLP]
DE69728447T 1996-05-31 1997-06-02 Veränderte, kleine rna-viren Expired - Lifetime DE69728447T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO0234A AUPO023496A0 (en) 1996-05-31 1996-05-31 Modified small RNA viruses
AUPO023496 1996-05-31
PCT/AU1997/000349 WO1997046666A1 (en) 1996-05-31 1997-06-02 Modified small rna viruses

Publications (2)

Publication Number Publication Date
DE69728447D1 true DE69728447D1 (de) 2004-05-06
DE69728447T2 DE69728447T2 (de) 2005-01-05

Family

ID=3794553

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728447T Expired - Lifetime DE69728447T2 (de) 1996-05-31 1997-06-02 Veränderte, kleine rna-viren

Country Status (8)

Country Link
US (1) US6251654B1 (de)
EP (1) EP1015560B1 (de)
JP (1) JP3945823B2 (de)
AT (1) ATE263234T1 (de)
AU (1) AUPO023496A0 (de)
CA (1) CA2256696C (de)
DE (1) DE69728447T2 (de)
WO (1) WO1997046666A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19737442C2 (de) * 1997-08-22 1999-06-24 Olfert Landt Tib Molbiol Synth Proteinumhüllte Polyribonukleinsäuren, ein Verfahren zu ihrer Herstellung und ihre Verwendung
WO2011018702A1 (en) * 2009-08-13 2011-02-17 Rhodes University A method of producing virus-like particles
WO2013103829A1 (en) * 2012-01-05 2013-07-11 Viracine Therapeutics Corporation Compositions and methods for screening antiviral agents
WO2023102515A2 (en) * 2021-12-02 2023-06-08 Texas Tech University System Single-chain immune modulator (scim)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2141583A1 (en) * 1992-08-14 1994-03-03 Peter D. Christian Insect viruses and their uses in protecting plants
US5698443A (en) * 1995-06-27 1997-12-16 Calydon, Inc. Tissue specific viral vectors
GB9412844D0 (en) * 1994-06-27 1994-08-17 Medical Res Council Improvements in or relating to therapeutic methods
WO1997020575A1 (en) * 1995-12-08 1997-06-12 The University Of Alabama At Birmingham Research Foundation Targeted adenovirus vectors

Also Published As

Publication number Publication date
WO1997046666A1 (en) 1997-12-11
EP1015560A1 (de) 2000-07-05
EP1015560B1 (de) 2004-03-31
CA2256696C (en) 2007-03-20
EP1015560A4 (de) 2002-01-16
DE69728447T2 (de) 2005-01-05
ATE263234T1 (de) 2004-04-15
JP2000511426A (ja) 2000-09-05
AUPO023496A0 (en) 1996-06-27
CA2256696A1 (en) 1997-12-11
US6251654B1 (en) 2001-06-26
JP3945823B2 (ja) 2007-07-18

Similar Documents

Publication Publication Date Title
DE60236864D1 (de) Chimere alphavirus-replikon-partikel
ATE328068T1 (de) Papillomavirus vakzine
DE60130987D1 (de) Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
ATE202487T1 (de) Mono- oder polyfunktionelle konjugate von polylysine
CY1105963T1 (el) Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης
MY139031A (en) Vaccine composition comprising virus-like particles of human papillomavirus
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
DE60034947D1 (de) Virusähnliche partikel, vorbereitung und verwendung in screening und funktionelle genomanwendung
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
ATE418997T1 (de) Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen
DE50208824D1 (de) Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen
DE69728447D1 (de) Veränderte, kleine rna-viren
WO2002078631A3 (en) Improved conditionally replicating vectors for inhibiting viral infections
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
ATE254457T1 (de) Wässrige flüssige pharmazeutische zusammensetzung enthaltend ein benzopyranderivat als hauptbestandteil
DE69528578D1 (de) Verändertes l2-protein des papillomavirus und damit gestellte viroide
DE60037263D1 (de) Virus-ähnliche Partikel, ihre Herstellung und ihre Verwendung beim pharmazeutischen Screening und funktionelle Genomanwendungen
DE122011100041I1 (de) In vitro-rekonstitution von segmentierten, negativstrang-rna-viren.
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
DE69425061D1 (de) Verwendung von einer suspension auf der basis von sucralfatgel als antazidum
DE60117561D1 (de) Verbesserte replikation von hcv rna
DE69434019D1 (de) Zusammensetzung von transdominanten varianten von virus- proteinen zur antiviralen wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition